Avinger, Inc. (AVGR) Financials

AVGR Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2024 13.6 million 9.7 million
June 30, 2024 17.3 million 9.5 million
March 31, 2024 16.9 million 20.9 million
Dec. 31, 2023 13.8 million 20.0 million

AVGR Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -2.9 million 222000
June 30, 2024 -3.6 million 207000
March 31, 2024 -4.7 million 1.1 million
Dec. 31, 2023 -3.4 million 237000

AVGR Net Income

No data available :(

AVGR Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 5.9 million 217000 -
June 30, 2024 8.8 million 528000 1.7 million
March 31, 2024 7.2 million 835000 2.0 million
Dec. 31, 2023 5.3 million - 1.1 million

AVGR Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 2.2 million
June 30, 2024 1.6 million
March 31, 2024 1.5 million
Dec. 31, 2023 1.3 million

AVGR Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - 1.1 million 3.0 million -
June 30, 2024 - 904000 3.6 million -
March 31, 2024 - 1.1 million 4.4 million -
Dec. 31, 2023 - 1.2 million 3.8 million -

AVGR Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 1.7 million 1.2 million
June 30, 2024 1.8 million 1.5 million
March 31, 2024 1.9 million 1.5 million
Dec. 31, 2023 1.9 million 1.5 million

AVGR

Price: $0.47

52 week price:
0.36
4.37

Payout Ratio Range:
-146.16%
-0.02%

Earnings Per Share: -8.76 USD

P/E Ratio: -0.05

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 84000

Ebitda: -8.5 million

Market Capitalization: 1.5 million

Links: